Zytokine sind zentrale Mediatoren der Proliferation, Differenzierung und Funktion von Zellen. Sie vermitteln und regulieren die Interaktionen verschiedener Zellen, die überwiegend zum Immunsystem und zur Hämatopoese gehören. Die Zytokine selbst besitzen keine Enzymaktivität. Sie haben häufig pleiotrope Effekte, die sich teilweise auch überlappen.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. An E, Ogata K, Kuriya S, Nomura T (1994) Interleukin-6 and erythropoietin act as direct potentiators and inducers of in vitro cytoplasmic process formation on purified mouse megakaryocytes. Exp Hematol 22:149–156PubMedGoogle Scholar
  2. Andrews RG, Knitter GH, Bartelmez et al. (1991) Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates. Blood 78:1975–1980PubMedGoogle Scholar
  3. Bauer J, Herrmann F (1991) Interleukin-6 in clinical medicine. Ann Hematol 62:203–210PubMedCrossRefGoogle Scholar
  4. Bedi A, Griffin CA, Barber JP et al. (1994) Growth factor-mediated terminal differentiation of chronic myeloid leukemia. Cancer Res 54:5535–5538PubMedGoogle Scholar
  5. Bellone G, Trinchieri G (1994) Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis. J Immunol 153:930–937PubMedGoogle Scholar
  6. Brenner MK (1994) Haematological applications of interleukin-2 and other immunostimulatory cytokines. Baillieres Clin Haematol 7:115–134PubMedCrossRefGoogle Scholar
  7. Brugger W, Mocklin W, Heimfeld S (1993) Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood 81:2579–2584PubMedGoogle Scholar
  8. Brummer E, Stevens, DA (1994) Macrophage colony-stimulating factor induction of enhanced macrophage anticryptococcal activity: synergy with fluconazole for killing. J Infect Dis 170:173–179PubMedCrossRefGoogle Scholar
  9. Case DC Jr, Bukowski RM, Carey RW et al. (1993) Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 85:801–806PubMedCrossRefGoogle Scholar
  10. Cenci E, Bartocci A, Puccetti P, Mocci S, Stanley ER, Bistoni F (1991) Macrophage colony-stimulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration. Infect Immunol 59:868–872Google Scholar
  11. Cosman D (1993) The hematopoietin receptor superfamily. Cytokine 5:95–106PubMedCrossRefGoogle Scholar
  12. Davis GL (1994) Interferon treatment of chronic hepatitis C. Am J Med 96:41S–46SPubMedCrossRefGoogle Scholar
  13. Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77:1627–1652PubMedGoogle Scholar
  14. Dinarello CA, Gelfand JA, Wolff SM (1993) Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 269:1829–1835PubMedCrossRefGoogle Scholar
  15. Dorr RT (1993) Interferon-alpha in malignant and viral diseases. A review. Drugs 45:177–211Google Scholar
  16. Du XX, Doerschuk CM, Orazi A, Williams DA (1994) A bone marrow stromalderived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 83:33–37PubMedGoogle Scholar
  17. Du XX, Williams DA (1994) Interleukin-11: a multifunctional growth factor derived from the hematopoietic microenvironment. Blood 83:2023–2030PubMedGoogle Scholar
  18. Dubucquoi S, Desreumaux P, Janin A et al. (1994) Interleukin-5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med 179:703–708PubMedCrossRefGoogle Scholar
  19. Erslev AJ (1991) Erythropoietin. N Engl J Med 324:1339–1344PubMedCrossRefGoogle Scholar
  20. Foa R (1993) Does interleukin-2 have a role in the management of acute leukemia? J Clin Oncol 11:1817–1825PubMedGoogle Scholar
  21. Fong Y, Lowry SF (1990) Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol 55:157–170PubMedCrossRefGoogle Scholar
  22. Geissler K, Valent P, Mayer P (1990) Recombinant human interleukin-3 expands the pool of circulating hematopoietic progenitor cells in primates — Synergism with recombinant human granulocyte/macrophage colony stimulating factor. Blood 75:2305–2310PubMedGoogle Scholar
  23. Geissler K, Valent P, Bettelheim P et al. (1992) In vivo synergism of recombinant human interleukin-3 and recombinant human interleukin-6 on thrombopoiesis in primates. Blood 79:1155–1160PubMedGoogle Scholar
  24. Gilleece MH, Scarffe JH, Ghosh A et al. (1992) Recombinant human Interleukin-4 (IL-4) given as daily subcutaneous injections-a phase I dose toxicity trial. Br J Cancer 66:204–210PubMedCrossRefGoogle Scholar
  25. Goodnough LT, Anderson KC, Kurtz S, Lane TA, Pisciotto PT, Sayers MH, Silberstein LE (1993) Indications and guidelines for the use of hematopoietic growth factors. Transfusion 33:944–959PubMedCrossRefGoogle Scholar
  26. Groopman JE, Molina JM, Scadden DT (1989) Hematopoietic growth factors. Biology and clinical applications. N Engl J Med 321:1449–1459PubMedCrossRefGoogle Scholar
  27. Gutterman JU (1994) Cytokine therapeutics: lessons from interferon alpha. Proc Natl Acad Sci USA 91:1198–1205PubMedCrossRefGoogle Scholar
  28. Hawkins MJ (1993) Interleukin-2 antitumor and effector cell responses. Semin Oncol 20:52–59PubMedGoogle Scholar
  29. Hilton DJ, Nicola NA, Metcalf D (1988) Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells. Proc Natl Acad Sci USA 85:5971–5975PubMedCrossRefGoogle Scholar
  30. Hirayama F, Katayama N, Neben S, Donaldson D, Nickbarg EB, Clark SC, Ogawa M (1994) Synergistic interaction between interleukin-12 and steel factor in support of proliferation of murine lymphohematopoietic progenitors in culture. Blood 83:92–98PubMedGoogle Scholar
  31. Hoang T, Levy B, Onetto N, Haman A, Rodriguez-Cimadevilla JC (1989) Tumor necrosis factor a stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor. J Exp Med 170:15–26PubMedCrossRefGoogle Scholar
  32. Holland G, Zlotnik A (1993) Interleukin-10 and cancer. Cancer Invest 11:751–758PubMedCrossRefGoogle Scholar
  33. Huber AR, Kunkel SL, Todd RF, Weiss SJ (1991) Regulation of transendothelial neutrophil migration by endogenous interleukin-8 [published errata appear in Science 1991 Nov 1;254(5032):631 and 1991 Dec 6;254(5037):1435]. Science 254:99–102PubMedCrossRefGoogle Scholar
  34. Hunter CA, Subauste CS, Van Cleave VH, Remington JS (1994) Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun 62:2818–2824PubMedGoogle Scholar
  35. Ibelgaufts H (1992) Lexikon Zytokine. Medikon, MünchenGoogle Scholar
  36. Jacobsen FW, Rusten LS, Jacobsen SE (1994) Direct synergistic effects of interleukin-7 on in vitro myelopoiesis of human CD34+ bone marrow progenitors. Blood 84:775–779PubMedGoogle Scholar
  37. Jacobsen SEW, Okkenhaug C, Veiby OP, Caput D, Ferrara P, Minty A (1994) Interleukin-13: Novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J Exp Med 180:75–82PubMedCrossRefGoogle Scholar
  38. Kaushansky K (1995) Thrombopoietin: The primary regulator of platelet production. Blood 86:419–431PubMedGoogle Scholar
  39. Kaushansky K, Lok S, Holly RD et al. (1994) Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369:568–569PubMedCrossRefGoogle Scholar
  40. Kobayashi M, Fitz L, Ryan M (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170:827–845PubMedCrossRefGoogle Scholar
  41. Legha SS, Buzaid AC (1993) Role of recombinant interleukin-2 in combination with interferon-alfa and chemotherapy in the treatment of advanced melanoma. Semin Oncol 20:27–32PubMedGoogle Scholar
  42. Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S (1994) Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells. Exp Hematol 22:919–923PubMedGoogle Scholar
  43. Lieschke GJ, Burgess AW (1992) Granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor (1). N Engl J Med 327:28–35PubMedCrossRefGoogle Scholar
  44. Lieschke GJ, Burgess AW (1992) Granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor (2). N Engl J Med 327:99–106PubMedCrossRefGoogle Scholar
  45. Link H, Boogaerts M, Fauser AA, Slavin S et al. (1994) A controlled trial of recombinant human erytropoietin after bone marrow transplantation. Blood 84:3327–3335PubMedGoogle Scholar
  46. Link H (1994) Inhibition oder Stimulation der Granulozyten bei Sepsis? Intensivmed 31:376–383Google Scholar
  47. Lok S, Kaushansky K, Holly RD (1994) Cloning and expression of murine thrombopoietin cDNA and Stimulation of platelet production in vivo. Nature 369:565–568PubMedCrossRefGoogle Scholar
  48. Lotzova E, Savary CA (1993) Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth. Nat Immun Cell Growth Regue 12:209–217Google Scholar
  49. Löwenberg B, Touw P (1993) Hematopoietic growth factors and their receptors in acute leukemia. Blood 81:281–292PubMedGoogle Scholar
  50. Lu L, Walker D, Graham CD, Waheed A, Shadduck RK, Broxmeyer, HE (1988) Enhancement of release from MHC class II antigen-positive monocytes of hematopoietic colony stimulating factors CSF-1 and G-CSF by recombinant human tumor necrosis factor-alpha: Synergism with recombinant human interferon-gamma. Blood 72:34–41PubMedGoogle Scholar
  51. McDonald TP, Sullivan PS (1993) Megakaryocytic and erythrocytic cell lines share a common precursor cell. Exp Hematol 21:1316–1320PubMedGoogle Scholar
  52. Metcalf D (1989) Actions and interactions of G-CSF, LIF and IL-6 on normal and leukemic murine cells. Leukemia 3:349–355PubMedGoogle Scholar
  53. Metcalf D (1993) Hematopoietic regulators: redundancy or subtlety? Blood 82:3515–3523PubMedGoogle Scholar
  54. Migliaccio G, Migliaccio AR, Valinsky J, Langley K, Zsebo K, Visser JW, Adamson JW (1991) Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells. Proc Natl Acad Sci USA 88:7420–7424PubMedCrossRefGoogle Scholar
  55. Moore MAS, Warren DJ (1987) Synergy of Interleukin-1 and granulocyte colony-stimulating factor: in vivo stimulation of stem cell recovery and hematopoietic regeneration following 5-fluorouracil-treatment of mice. Proc Natl Acad Sci USA 84:7134–7138PubMedCrossRefGoogle Scholar
  56. Moreau J-F, Donaldson DD, Bennett F (1988) Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells. Nature 336:690–692PubMedCrossRefGoogle Scholar
  57. Morstyn G, Dexter TM (1994) Filgrastim (r-metHuG-CSF) in clinical practice. Dekker, New YorkGoogle Scholar
  58. Mosmann TR (1994) Properties and functions of interleukin-10. Adv Immunol 56:1–26PubMedCrossRefGoogle Scholar
  59. Nemunaitis J, Meyers JD, Buckner CD et al (1991) Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood 78:907–913PubMedGoogle Scholar
  60. Ogawa M (1993) Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844–2853PubMedGoogle Scholar
  61. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K (1991) Properties of the novel proinflammatory supergene „intercrine“cytokine family. Annu Rev Immunol 9:617–648PubMedCrossRefGoogle Scholar
  62. Paul WE (1991) Interleukin-4: prototypic immunoregulatory lymphokine. Blood 77:1859–1870PubMedGoogle Scholar
  63. Paul SR, Bennett F, Calvetti JA et al. (1990) Molecular cloning of a cDNA encoding Interleukin-11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci U S A 87:7512–7516PubMedCrossRefGoogle Scholar
  64. Renauld JC, Houssiau F, Louahed J, Vink A, Van Snick J, Uyttenhove C (1993) Interleukin-9. Adv Immunol 54:79–97PubMedCrossRefGoogle Scholar
  65. Rubin JT (1993) Interleukin-2: its biology and clinical application in patients with cancer. Cancer Invest 11 460–472PubMedCrossRefGoogle Scholar
  66. Sanderson CJ (1992) Interleukin-5, eosinophils, and disease. Blood 79:3101–3109PubMedGoogle Scholar
  67. Schaafsma MR, Falkenburg JH, Duinkerken N, Van Snick J, Landegent JE, Willemze R, Fibbe, WE (1993) Interleukin-9 stimulates the proliferation of enriched human erythroid progenitor cells: additive effect with GM-CSF. Ann Hematol 66:45–49PubMedCrossRefGoogle Scholar
  68. Sironi M, Sciacca FL, Matteucci C et al. (1994) Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 84:1913–1921PubMedGoogle Scholar
  69. Soiffer RJ, Robertson MJ, Murray C, Cochran K, Ritz J (1993) Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood 82:2790–2796PubMedGoogle Scholar
  70. Spits H, Lanier LL, Phillips JH (1995) Development of human T and natural killer cells. Blood 85:2654–2670PubMedGoogle Scholar
  71. Takahashi GW, Andrews III DF, Lilly MB, Singer JW, Alderson, MR (1993) Effect of granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8 production by human neutrophils and monocytes. Blood 81:357–364PubMedGoogle Scholar
  72. Takatsu K (1991) Interleukin-5 (11–5) and its receptor. Microbiol Immunol 35:593–606PubMedGoogle Scholar
  73. Villiers WJ de, Fraser IP, Hughes DA, Doyle AG, Gordon S (1994) Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. J Exp Med 180:705–709PubMedCrossRefGoogle Scholar
  74. Welch PA, Namen AE, Goodwin RG, Armitage R, Cooper, MD (1989) Human IL-7: A novel T cell growth factor. J Immunol 143:3562–3567PubMedGoogle Scholar
  75. Whittington R, Faulds D (1993) Interleukin-2; a review of its pharmacological properties and therapeutic use in patients with cancer. Drugs 46:446–514PubMedCrossRefGoogle Scholar
  76. Williams RL, Hilton DJ, Pease S et al. (1988) Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336:684–688PubMedCrossRefGoogle Scholar
  77. Wolf SF, Sieburth D, Sypek J (1994) Interleukin-12: a key modulator of immune function. Stem Cells (Dayt) 12:154–168CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Heidelberg 1996

Authors and Affiliations

  • H. Link

There are no affiliations available

Personalised recommendations